Dr. Mridula George, MD
Claim this profileRutgers Cancer Institute of New Jersey
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
30 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
Stage III
2Cancer
Stage IV
HER2 negative
Stage III
Affiliated Hospitals
Clinical Trials Mridula George, MD is currently running
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
More about Mridula George, MD
Clinical Trial Related1 year of experience running clinical trials · Led 11 trials as a Principal Investigator · 7 Active Clinical TrialsTreatments Mridula George, MD has experience with
- Tucatinib
- Placebo
- Pelareorep
- Paclitaxel
- Trastuzumab
- Pertuzumab
Breakdown of trials Mridula George, MD has run
Breast Cancer
Cancer
Cardiotoxicity
Cardiac Toxicity
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mridula George, MD specialize in?
Mridula George, MD focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 negative.
Is Mridula George, MD currently recruiting for clinical trials?
Yes, Mridula George, MD is currently recruiting for 7 clinical trials in New Brunswick New Jersey. If you're interested in participating, you should apply.
Are there any treatments that Mridula George, MD has studied deeply?
Yes, Mridula George, MD has studied treatments such as Tucatinib, Placebo, Pelareorep.
What is the best way to schedule an appointment with Mridula George, MD?
Apply for one of the trials that Mridula George, MD is conducting.
What is the office address of Mridula George, MD?
The office of Mridula George, MD is located at: Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey 08903-2681 United States. This is the address for their practice at the Rutgers Cancer Institute of New Jersey.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.